Sinil Pharmaceutical Co., Ltd.

KOSDAQ:A012790 Stok Raporu

Piyasa değeri: ₩81.1b

Sinil Pharmaceutical Temettü

Temettü kriter kontrolleri 2/6

Sinil Pharmaceutical is a dividend paying company with a current yield of 2.38%.

Anahtar bilgiler

2.4%

Temettü verimi

0.09%

Geri Alım Getirisi

Toplam Hissedar Getirisi2.5%
Gelecekteki Temettü Verimin/a
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettü₩170.000
Ödeme oranın/a

Son temettü güncellemeleri

Recent updates

Little Excitement Around Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Earnings

Aug 12
Little Excitement Around Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Earnings

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Mar 11
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Feb 13
Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Jan 17
Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Dec 22
Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Nov 26
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Whilst dividend payments have been stable, A012790 has been paying a dividend for less than 10 years.

Büyüyen Temettü: A012790's dividend payments have increased, but the company has only paid a dividend for 3 years.


Piyasaya Karşı Temettü Getirisi

Sinil Pharmaceutical Piyasaya Karşı Temettü Getirisi
A012790 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (A012790)2.4%
Pazarın Alt %25'i (KR)1.2%
Pazarın En İyi %25'i (KR)3.8%
Sektör Ortalaması (Pharmaceuticals)1.0%
Analist tahmini (A012790) (3 yıla kadar)n/a

Önemli Temettü: A012790's dividend (2.38%) is higher than the bottom 25% of dividend payers in the KR market (1.18%).

Yüksek Temettü: A012790's dividend (2.38%) is low compared to the top 25% of dividend payers in the KR market (3.75%).


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate A012790's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: With its low cash payout ratio (12.1%), A012790's dividend payments are thoroughly covered by cash flows.


Güçlü temettü ödeyen şirketleri keşfedin